IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — PRME

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022
Cash & Equivalents47.4564.1171.4053.8091.88117.9855.6094.1643.96120.58133.4647.95
Total Current Assets96.80137.89231.41121.29163.76246.07170.80217.65184.53218.49253.50148.85
Property, Plant & Equipment17.0818.8222.0523.8324.9623.2923.8123.9322.0320.5621.5914.97
Total Non-current Assets*152.24156.84153.61157.72164.4086.7188.9093.7354.6162.3863.4566.42
Total Assets249.04294.73385.01279.01328.16332.78259.71311.38239.15280.87316.95215.27
Accounts Payable5.8112.339.356.3810.035.434.6410.0814.125.494.564.11
Total Current Liabilities31.6936.2935.0234.1134.2937.8820.7524.4439.3728.7223.8722.22
Total Non-current Liabilities*177.54181.74188.17184.04186.95105.4042.3743.185.8212.0414.2720.34
Total Liabilities209.23218.03223.19218.15221.24143.2863.1267.6245.1940.7638.1542.56
Retained Earnings(979.58)(937.48)(842.27)(791.69)(739.10)(644.94)(592.42)(537.09)(425.69)(374.98)(332.59)(253.91)
Total Stockholder Equity39.8176.70161.8260.86106.92189.50196.59243.77193.96240.10278.80(223.10)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Total Revenue----0.841.231.121.452.180.210.000.590.000.000.000.00----
Research & Development33.4034.1034.7143.9941.3840.5634.1040.3443.0737.7741.46----30.8829.0625.05
Selling, General & Admin11.0417.4114.7411.2113.1213.2812.3014.1012.6011.1613.0810.4910.669.159.636.61
Total Operating Expenses44.4451.5149.4555.2054.4953.8546.4154.4455.6748.9368.0451.4645.2640.0338.6931.66
Operating Income(43.28)(50.65)(48.61)(53.97)(53.38)(52.39)(44.22)(54.23)(55.67)(48.34)(68.04)(51.46)(45.26)(40.03)(38.69)(31.65)
Pretax Income*--------(52.59)(51.89)(42.28)(52.52)(55.46)(45.63)(65.64)(50.82)(42.35)(39.60)(39.47)(29.14)
Tax Provision--------0.000.000.000.00(0.13)0.130.00(0.11)0.03(0.20)(0.19)0.21
Net Income(42.11)(49.12)(46.08)(50.58)(52.59)(51.89)(42.28)(52.52)(55.33)(45.76)(65.64)(50.71)(42.38)(39.40)(39.28)(29.35)
Basic EPS(0.24)(0.28)(0.22)(0.32)(0.41)(0.40)(0.31)(0.44)(0.46)(0.44)(0.72)(0.55)(0.47)(0.44)0.72(1.61)
Diluted EPS(0.24)(0.28)(0.22)(0.32)(0.41)(0.40)(0.31)(0.44)(0.46)(0.44)(0.72)(0.55)(0.47)(0.44)0.72(1.61)

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
Operating Cash Flow(41.05)(42.71)(37.26)(35.04)(41.41)(48.86)16.25(25.91)(45.49)(67.71)(43.86)(39.17)(40.82)(41.56)(30.71)(101.11)
Capital Expenditures0.050.210.290.251.572.421.791.281.902.321.842.911.982.004.8111.28
Free Cash Flow*(41.09)(42.92)(37.55)(35.29)(42.98)(51.28)14.45(27.19)(47.39)(70.03)(45.70)(42.07)(42.80)(43.56)(35.53)(112.39)
Investing Cash Flow24.0343.3928.33(92.12)2.77(47.74)48.2550.346.89(37.03)41.29(37.77)27.86(12.66)(13.69)(33.41)
Financing Cash Flow0.360.390.56144.750.206.000.0038.510.04157.330.190.320.080.07184.07(2.58)

* Derived from reported values